Simple cream may shield transplant patients from skin cancer
NCT ID NCT07286318
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily application of 5% niacinamide cream can prevent skin cancer in organ transplant recipients, who are at high risk due to long-term immune-suppressing drugs. Twenty adult transplant recipients with a history of precancerous skin spots and at least one prior skin cancer will use either the cream plus sunscreen or sunscreen alone for 12 months. Researchers will count skin spots and new cancers at 6 and 12 months to see if the cream offers extra protection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS (AK) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC Falk Dermatology
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
-
UPMC St Margarets Dermatology
RECRUITINGPittsburgh, Pennsylvania, 15238, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tiny biopsy outsmart skin Cancer's spread?
- Can your genes predict your melanoma risk?
- A UV photo and a cheek swab may be the keys to stopping sunburn before it starts
- Can a reformulated gel plus light therapy better tackle precancerous skin spots?
- Immunotherapy may treat skin cancer in kidney transplant patients without rejection
- Laser rejuvenation may shield aging skin from cancer